Evidence map›Paper›PMID 38547292›Full record

ArticleScience (New York, N.Y.)2024

Control of cell proliferation by memories of mitosis.

Franz Meitinger, Hazrat Belal, Robert L Davis, Mallory B Martinez, Andrew K Shiau, Karen Oegema, Arshad Desai

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cell confinement initiates a delayed but heritable loss of chromosomes.bioRxiv : the preprint server for biology · 2026
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Franz MeitingerDepartment of Cell and Developmental Biology, School of Biological Sciences, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-8635-9078
Hazrat BelalOkinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan.ORCID 0000-0002-2192-8727
Robert L DavisSmall Molecule Discovery Program, Ludwig Institute for Cancer Research, La Jolla, CA 92093, USA.
Mallory B MartinezSmall Molecule Discovery Program, Ludwig Institute for Cancer Research, La Jolla, CA 92093, USA.ORCID 0009-0000-7047-260X
Andrew K ShiauDepartment of Cell and Developmental Biology, School of Biological Sciences, University of California San Diego, La Jolla, CA 92093, USA.
Karen OegemaDepartment of Cell and Developmental Biology, School of Biological Sciences, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-8515-7514
Arshad DesaiDepartment of Cell and Developmental Biology, School of Biological Sciences, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-5410-1830

Funding

Kinetochore Specification and FunctionR01GM074215 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DESAI, ARSHAD · 2005 to 2025
$8.2M
Analysis of Centrosome DynamicsR01GM074207 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OEGEMA, KAREN F · 2006 to 2025
$6.6M
NIGMS NIH HHS R01 GM074207NIGMS NIH HHS R01 GM074215
6 · The paper itself

Abstract

Mitotic duration is tightly constrained, and extended mitosis is characteristic of problematic cells prone to chromosome missegregation and genomic instability. We show here that mitotic extension leads to the formation of p53-binding protein 1 (53BP1)-ubiquitin-specific protease 28 (USP28)-p53 protein complexes that are transmitted to, and stably retained by, daughter cells. Complexes assembled through a Polo-like kinase 1-dependent mechanism during extended mitosis and elicited a p53 response in G

Indexed as

Cell ProliferationMitosisNeoplasmsTumor Suppressor p53-Binding Protein 1Ubiquitin ThiolesteraseAntimitotic AgentsCell Line, TumorDrug Resistance, NeoplasmGenomic InstabilityHumansPolo-Like Kinase 1Tumor Suppressor Protein p53Antimitotic AgentsPLK1 protein, humanPolo-Like Kinase 1TP53BP1 protein, humanTP53 protein, humanTumor Suppressor p53-Binding Protein 1Tumor Suppressor Protein p53Ubiquitin ThiolesteraseUSP28 protein, human

Identifiers

PMID38547292
PMCPMC11621110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.